Maximum quantity allowed is 999
CAS RN: 7491-74-9 | Product Number: P2880
Piracetam

Purity: >98.0%(GC)(T)
- 2-(2-Oxopyrrolidin-1-yl)acetamide
- 2-(2-Oxopyrrolidino)acetamide
- 2-Oxo-1-pyrrolidineacetamide
Size | Unit Price | Hyderabad | Japan* | Quantity |
---|---|---|---|---|
10G |
₹4,700.00
|
3 | 9 |
|
50G |
₹9,800.00
|
1 | 16 |
|
*Upon orders receipt, Hyderabad stocks will be dispatched on the same day.
*Items available in Japan warehouse will be dispatched in 10-12 working days.
*INR price is exclusive of domestic taxes applicable.
*TCI frequently reviews storage conditions to optimize them. Please note that the latest information on the storage temperature for the products is described on our website.
Product Number | P2880 |
Purity / Analysis Method ![]() |
>98.0%(GC)(T) |
Molecular Formula / Molecular Weight | C__6H__1__0N__2O__2 = 142.16 |
Physical State (20 deg.C) | Solid |
Storage Temperature ![]() |
Refrigerated (0-10°C) |
Store Under Inert Gas | Store under inert gas |
Condition to Avoid | Air Sensitive,Heat Sensitive |
CAS RN | 7491-74-9 |
Reaxys Registry Number | 1526393 |
PubChem Substance ID | 468592761 |
MDL Number | MFCD00079246 |
Appearance | White to Light yellow powder to crystal |
Purity(GC) | min. 98.0 % |
Purity(Volumetric Analysis) | min. 98.0 % |
Melting point | 152.0 to 156.0 °C |
NMR | confirm to structure |
Melting Point | 153 °C |
Solubility in water | Soluble |
Solubility (slightly sol. in) | Ethanol |
Solubility (insoluble in) | Diethyl ether |
RTECS# | UX9660500 |
References
- Piracetam and other structurally related nootropics (a review)
- Piracetam: A review of pharmacological properties and clinical uses
- Piracetam and piracetam-like drugs: from basic science to novel clinical applications to CNS disorders (a review)
Safety Data Sheet (SDS)
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Sample C of A
A sample C of A for this product is not available at this time.
Analytical Charts
The requested analytical chart is not available. Sorry for the inconvenience.